Adderall is the most common drug for which children with ADHD receive treatment in the United States

F.D.A. Confirms Widespread Shortages of Adderall

In a news conference this morning, the Food and Drug Administration (F.D.A.) announced that its staff had issued a formal recommendation to the agency to approve the drug for use in children as part of a treatment program for Attention Deficit Hyperactivity Disorder (ADH) and that the agency had received more than 10,000 letters in favor of this treatment initiative. The agency expects to decide by the end of the week whether or not to act.

ADHD is a common and debilitating disorder that affects 4 to 6 percent of children. It occurs from early childhood to late adolescence. A primary symptom of the disease is the inability to focus and pay attention. More than two thirds of children with ADHD have additional symptoms, including restlessness, anxiety, depression, trouble sleeping, and inattentiveness. It is estimated that there are more than 5 million children diagnosed with ADHD. A fourth of them have serious problems in addition to ADHD, including behavioral problems, conduct disorders, and emotional disorders.

The drug for which the agency is considering approving the drug, a pill called Adderall, is a stimulant that comes in the form of a tablet. It contains the dopamine (Dopatop) neurotransmitter. Stimulant drugs, like Adderall, increase the effect of your brain on your body. They help control your thoughts and behavior, which are often impeded by the fact that your frontal lobe, the part of your brain that controls many of your thoughts and behaviors, is not functioning properly.

ADHD is often diagnosed in children who exhibit behavior problems such as inattention, restlessness, hyperactivity, and impulsivity. Many people with ADHD have a history of behavioral problems; however, ADHD itself is not a symptom of the illness. Diagnostic criteria for ADHD vary from one country to another. It is now the most common disorder for which children receive treatment in the United States.

The decision by the F.D.A

Leave a Comment